Quest Resource Holding Partners with Corewell Health to Modernize Michigan's Laboratory Services
- Quest Diagnostics and Corewell Health launched a joint venture, Diagnostic Lab of Michigan, to enhance laboratory services in Michigan.
- Quest will manage Corewell Health’s 21 existing hospital laboratories alongside the new facility, ensuring service continuity and quality.
- The partnership emphasizes Quest's commitment to innovative diagnostic services and expands its presence in key healthcare growth areas.
Quest Diagnostics and Corewell Health Launch Joint Venture to Transform Laboratory Services in Michigan
In a significant move to enhance healthcare delivery, Quest Diagnostics and Corewell Health announce their joint venture, Diagnostic Lab of Michigan, LLC. Set to establish a cutting-edge, 100,000-square-foot laboratory facility at the Corewell Health Southfield Center in Southfield, Michigan, the partnership aims to modernize laboratory services throughout the region. This strategic collaboration, unveiled on August 26, 2025, reflects a shared commitment to improving patient care through advanced technology and operational efficiency.
The new laboratory will leverage state-of-the-art technologies, including automated microbiology and high-throughput molecular testing, to deliver innovative and affordable diagnostic services. By integrating these advanced capabilities, the facility seeks to meet the growing demands of physicians and patients alike, ensuring timely and accurate results. Quest Diagnostics will oversee the management of Corewell Health’s 21 existing hospital laboratories, which will continue to function even after the new facility becomes operational. This comprehensive approach not only enhances service quality but also maintains continuity in laboratory operations across the health system.
Quest Diagnostics' implementation of its Collaborative Lab Solutions (Co-Lab) further underscores the depth of this partnership. Co-Lab encompasses comprehensive laboratory management services, workforce support, supply chain management, and analytics, aimed at optimizing the performance of Corewell Health's hospital labs. Corewell Health's Chief Operating Officer, Chad Tuttle, articulates the excitement surrounding this venture, emphasizing Quest’s dedication to providing high-quality, patient-centric diagnostic services. Jim Davis, CEO of Quest Diagnostics, highlights the venture as a fusion of Corewell's academic prowess and local insights with Quest's capabilities in diagnostic innovation, ultimately enhancing access to quality healthcare services.
In addition to the operational advancements, this joint venture aligns with Quest Diagnostics' broader strategy of expanding its presence in key growth areas through partnerships with prominent health systems. The ownership structure—51% Quest and 49% Corewell Health—reflects a collaborative approach that aims to maximize the benefits for both organizations while ensuring a focus on improving patient outcomes.
As the healthcare landscape continues to evolve, the Diagnostic Lab of Michigan emerges as a pivotal development, representing a commitment to advancing laboratory services and enhancing operational efficiencies within the sector. This joint venture not only reflects a significant investment in Michigan's healthcare infrastructure but also sets a precedent for future collaborations aimed at transforming patient care through innovation and quality service delivery.